Cargando…

ANCA glomerulonephritis after the Moderna COVID-19 vaccination

Detalles Bibliográficos
Autores principales:	Sekar, Arjun, Campbell, Ruth, Tabbara, Jad, Rastogi, Prerna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society of Nephrology. Published by Elsevier Inc. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166044/ https://www.ncbi.nlm.nih.gov/pubmed/34081948 http://dx.doi.org/10.1016/j.kint.2021.05.017

Ejemplares similares

ANCA-Associated Vasculitis after Moderna COVID-19 Vaccination
por: Gen, Shiko, et al.
Publicado: (2023)

Membranous glomerulonephritis with superimposed ANCA-associated vasculitis: another case report
por: Granata, Antonio, et al.
Publicado: (2011)

Is COVID-19 vaccination unmasking glomerulonephritis?
por: Tan, Hui Zhuan, et al.
Publicado: (2021)

Crescentic glomerulonephritis with anti-PR3 ANCA associated with Bartonella henselae infective endocarditis
por: Andrian, Titus, et al.
Publicado: (2022)

Unusual association of a positive pANCA pauci-immune extracapillary glomerulonephritis in a lupus patient
por: Fadili, W., et al.
Publicado: (2012)

Comment on a case of pityriasis rosea shortly after Moderna COVID-19 vaccination
por: Drago, Francesco, et al.
Publicado: (2022)

De novo immune complex–mediated membranoproliferative glomerulonephritis after COVID-19 vaccination
por: Zagorec, Nikola, et al.
Publicado: (2023)

pANCA autoantibody testing by indirect immunofluorescence indicates interstitial arteritis independent of MPO-ANCA immunoassays in ANCA-associated glomerulonephritis
por: Hakroush, Samy, et al.
Publicado: (2022)

Memantine treats psychosis and agitation associated with Moderna COVID-19 vaccine
por: Siao, Wen-Huei, et al.
Publicado: (2023)

Chest Pain with New Abnormal Electrocardiogram Development after Injection of COVID-19 Vaccine Manufactured by Moderna
por: Takase, Bonpei, et al.
Publicado: (2021)

COVID-19 vaccination precipitating de novo ANCA-associated vasculitis: clinical implications
por: Mai, Aaron Shengting, et al.
Publicado: (2022)

Increase in the number of new cases of ANCA-associated vasculitis in the COVID-19 vaccine era
por: Sato, Tomohito, et al.
Publicado: (2023)

Disparity in Public Perception of Pfizer and Moderna COVID-19 Vaccines on TikTok
por: Baumel, Nicholas M., et al.
Publicado: (2022)

G-CSF-induced ANCA associated glomerulonephritis in the presence of silent membranous “full house nephropathy” in an altruistic bone marrow donor
por: Angel Korman, Avital, et al.
Publicado: (2022)

De Novo ANCA-Associated Vasculitis With Glomerulonephritis in COVID-19
por: Uppal, Nupur N., et al.
Publicado: (2020)

De novo vasculitis after mRNA-1273 (Moderna) vaccination
por: Anderegg, Manuel A., et al.
Publicado: (2021)

“Covid arm”: Abnormal side effect after Moderna COVID‐19 vaccine
por: Picone, Vincenzo, et al.
Publicado: (2021)

Indeterminate mycobacterium tuberculosis QuantiFERON post Moderna mRNA Covid-19 vaccination
por: Wang, Samuel S.Y.
Publicado: (2022)

Incidence and Temporal Trend in Risk Factors of Severe Infections in ANCA-Glomerulonephritis Patients
por: Jourdain, Pierre, et al.
Publicado: (2021)

Histologic correlates of gross hematuria following Moderna COVID-19 vaccine in patients with IgA nephropathy
por: Kudose, Satoru, et al.
Publicado: (2021)

IgA nephropathy presenting as rapidly progressive glomerulonephritis following first dose of COVID-19 vaccine
por: Niel, Olivier, et al.
Publicado: (2021)

Severe de novo liver injury after Moderna vaccination – not always autoimmune hepatitis
por: Nyein, Chan Maung, et al.
Publicado: (2022)

Case Report: Patient with Hepatitis C, p-ANCA, and Cryoglobulin Antibodies Presenting with Necrotizing Crescentic p-ANCA Glomerulonephritis
por: Hanna, Ramy M., et al.
Publicado: (2018)

Covid-19 vaccine management (Comirnaty and mrna-1273 Moderna) in a teaching hospital in Italy: a short report on the vaccination campaign
por: Papini, Francesca, et al.
Publicado: (2021)

High prevalence of Chlamydophila pneumoniae infection in patients with myeloperoxidase antineutrophil cytoplasmic autoantibody (MPO-ANCA)-associated glomerulonephritis
por: Kawaguchi, Takehiko, et al.
Publicado: (2008)

Re: Heterologous Gam-COVID-Vac (Sputnik V)/mRNA-1273 (Moderna) vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

De Novo ANCA-Negative Pauci-Immune Crescentic Glomerulonephritis After COVID-19 mRNA Vaccination: A Case Report
por: Cho, Heejin, et al.
Publicado: (2023)

Immune-mediated hepatitis with the Moderna vaccine, no longer a coincidence but confirmed
por: Zin Tun, Gloria Shwe, et al.
Publicado: (2022)

ANCA negative pauci-immune glomerulonephritis with systemic involvement
por: Sampathkumar, K., et al.
Publicado: (2010)

Crescentic Glomerulonephritis with Anti-GBM and p-ANCA Antibodies
por: Javed, Tariq, et al.
Publicado: (2012)

ANCA-positive pauci-immune glomerulonephritis and febuxostat treatment
por: Izzedine, Hassane, et al.
Publicado: (2012)

Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis
por: Syed, Rafeel, et al.
Publicado: (2015)

ANCA-Associated Glomerulonephritis: Risk Factors for Renal Relapse
por: Göçeroğlu, Arda, et al.
Publicado: (2016)

MPO-C-ANCA-associated necrotising and crescentic glomerulonephritis
por: Koratala, Abhilash, et al.
Publicado: (2017)

What is the prognosis of ANCA-associated glomerulonephritis with immune deposition?
por: Xiao, Xiang, et al.
Publicado: (2022)

MPO-ANCA Rapidly Progressive Glomerulonephritis with Immune Deposits
por: Acosta, Eric, et al.
Publicado: (2022)

Heterologous Gam-COVID-Vac (Sputnik V)/mRNA-1273 (Moderna) vaccination: Author's response
por: Pereson, Matías J., et al.
Publicado: (2022)

Adapted treatment of ANCA-associated vasculitis during the COVID-19 pandemic
por: Nimmo, Ailish, et al.
Publicado: (2021)

Comparative Histological Subtyping of Immune Cell Infiltrates in MPO-ANCA and PR3-ANCA Glomerulonephritis
por: Hakroush, Samy, et al.
Publicado: (2021)

COVID-19 in a patient with hypocomplementemic urticarial syndrome and MPO-ANCA vasculitis on hemodialysis treated with omalizumab()
por: Baldallo, Cinthia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o4liea4s1n8t62t0g7verfk55q